Tuesday, 02 January 2024 12:17 GMT

Microbix Biosystems Inc.


(MENAFN- Baystreet) 10:03 AM EST - Microbix Biosystems Inc.: Announces that it is presenting results of its novel Quality Assessment Products and platform technology for supporting the quality management and reproducibility of Molecular Pathology derived diagnoses of infectious diseases at Labquality Days, a lab diagnostics conference taking place in Helsinki, Finland from February 5 to 6. Microbix Biosystems Inc. shares T are trading down $0.01 at $0.22.

MENAFN04022026000212011056ID1110695490



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search